每日市场观察 2025 年 7 月 2 日 【今日关注】 周二 A 股全天走势波动不大，收盘三大股指涨跌互现，沪指涨 0.39%， 深证成指涨 0.11%，创业板指跌 0.24%。沪深两市成交额接近 1.5 万亿 元，较前一交易日小幅缩量；行业板块方面，医药、有色、银行、建 材等行业涨幅居前，医药板块里的创新药、免疫治疗、减肥药、维生 素等细分行业表现亮眼，其它概念板块中，光刻机、超导、可控核聚 变等板块也是盘中热点，两市上涨股票数量超过 2600 多只。 三大股指全日小幅整理，市场表现有细微的分化现象，沪指收涨盘中 走势全日飘红但上涨幅度不大，创业板全天在前一交易日收盘下方运 行，收盘小幅下跌；个股涨跌数量基本相当，显示出市场在经过前一 交易周的上涨过后，技术形态需要整固，短线大盘波动幅度不大，市 场运行节奏延续结构性热点轮动，关注中报预告行情。 近日国家医保局联合国家卫生健康委出台《支持创新药高质量发展的 若干措施》，加强医疗、医保、医药三方信息互通，支持医保数据用 于创新药研发，推动创新药研发国家科技重大专项，创新药行业在政 策大力支持和技术创新提速的驱动下成为医药行业热点。近期市场关 注度主要集中在科 ...

近期市场情绪的抬升，正获得资金面的有力验证。 近期，A股市场量价齐升。在这轮攻势背后，头部私募机构正以真金白银的仓位布局A股—— 全市场股 票私募机构平均仓位继续运行在今年以来的相对高位，近九成百亿级股票私募机构的仓位超50%。 一线私募认为，海外风险趋缓、政策预期升温与市场内生修复动能形成合力，共同点燃本轮行情。随着 中报业绩预告时间窗口的临近， 私募机构将投资目光聚焦于科技成长、红利防御与消费复苏三大主 线，预期市场中期表现值得期待。 机构仓位整体高位运行 来自第三方机构私募排排网的监测数据显示，私募机构已进入"较高仓位状态"。截至6月20日，全市场 股票私募平均仓位达74.62%，较前一周小幅上升0.37个百分点，这一数值处于今年以来的中等偏高水 平。 百亿级股票私募机构的仓位更为激进。 截至6月20日， 百亿级股票私募机构 平均仓位为 79.43%， 显著 高于行业均值，处于今年以来的高位区间。 其中，有52.99%的百亿级股票私募机构处于重仓或满仓状 态（仓位大于80%），另有35.63%的百亿级股票私募机构的仓位处于中等偏高水平（仓位在50%至80% 之间）。这意味着近九成（88.62%）百亿级股 ...

本文首发于公众号"私募排排网"。 （点击↑↑ 上图查看详情 ） 迈入7月，今年上半年的行情于昨日正式收官。受海内外多重因素交织影响，A股的表现较为震 荡，主要股指全线上涨，其中上证指数上半年累涨2.76%，北证50指数大涨39.45%一度创出历史 新高。行业和题材方面，结构性分化明显，并呈现科技和红利共振的局面。 在此背景下，今年上半年基金行业也发生了许多引发市场热议的大事件。1月末，DeepSeek的创 始人梁文锋、背后公司幻方量化迅速出圈。4月，在关税冲击下，多家知名私募巨头集体发声并 用真金白银支持中国市场。5月，公募市场系统性改革文件落地，行业开始从"重规模"向"重回 报"转变。 0 1 幻方旗下 DeepSeek 出圈！私募量化巨头掀起 AI 布局热潮 今年1月，千亿私募巨头幻方量化旗下新一代AI大模型 DeepSeek-R1横空出世。DeepSeek-R1在 实现复杂逻辑推理解题能力的同时，训练成本约为GPT-4的1/10， 打破 "高投入=高性能"行业规 则 ， 因此在 全球技术圈和资本市场均引起巨大轰动，"东升西降"的说法更是开始甚嚣尘上。 资料显示，DeepSeek的研发经费主要依赖背后的量 ...

Group 1 - Beijing is focusing on the medical sector's needs by developing a second negative list for medical devices, following the first list that included five fields [1] - The city has established a comprehensive reform system for cross-border data flow, aiming to upgrade from the initial version to a more efficient and secure model [1][2] - The second negative list will include five sectors: medical devices, intelligent connected vehicles, trade logistics, banking, and public funds, expanding the coverage of the policy [2] Group 2 - A pilot program for the negative list will be implemented on a case-by-case basis for medical enterprises, with several companies already expressing interest in participation [3] - The focus will be on enhancing data flow for research collaboration, drug development, and multi-center consultations, encouraging partnerships between local hospitals and multinational pharmaceutical companies [3]

Report Industry Investment Rating - The report is optimistic about the investment value of the non - banking financial sector, believing it can enjoy both Beta and Alpha [4]. Core Viewpoints of the Report - Policy interpretation: Since 2022, reform measures for public funds have been gradually implemented, focusing on fees, assessment, and compensation. Future reforms are expected to be fully rolled out in the next three years. Floating fees will expand coverage, and fee reform phases are about to be implemented. Benchmark constraints and assessment will influence industry allocation and investment focus [4]. - Impact on public funds: The industry pattern will be optimized, with benchmark constraints potentially forcing active equity funds to become "quasi - passive". Investment research will first follow the benchmark and then pursue excess returns. Passive products will continue to develop, and channels, talent, and back - end operations will face corresponding adjustments [4]. - Impact on securities companies: The profit contribution of publicly - held funds by securities companies will show greater differentiation, and the advantage of securities companies in selling equity index funds will expand [4]. - Investment analysis opinion: The non - banking financial sector is a sector that can enjoy both Beta and Alpha, and its investment value is promising [4]. Summary by Relevant Catalogs 1. Policy Interpretation: Promote the High - quality Development of the Public Fund Industry in Multiple Dimensions - Regulatory roadmap: Since 2022, the roadmap and schedule for the high - quality development of public funds have become clearer. Reforms started with fee reduction and are now being comprehensively rolled out. The "Action Plan" covers aspects not implemented in the 2022 "Opinions" [8][10][12]. - Comparison of 2022 and 2025 reform requirements: The 2025 requirements are more detailed and quantitative, covering aspects such as overall requirements, differentiated development, long - term incentive constraints, and product innovation [13]. - Key points of the "Action Plan": It includes establishing a floating management fee mechanism, reducing investor costs, increasing the scale and proportion of equity investment, establishing a performance - based assessment system, strengthening regulatory classification evaluation, and enhancing compensation management [14][15][16][18][19][20]. - Reasons for the "Three - Year Goal": Investor risk preferences have declined, leading to a slowdown in the growth of public funds, especially new equity funds. The "Long - term Capital Market Entry" has set a 10% quantitative requirement for public fund capital entry [27][25]. - Fee reform: It aims to establish a floating fee mechanism linked to performance and reduce investment costs. It also expands the scope of fee reduction and promotes the development of floating - rate funds [31][32][36]. - Differentiated competition: Fee reduction and classification supervision will optimize the industry pattern, benefiting public funds strong in equity and index products [44][48]. - Benchmark constraints and long - term assessment: In the short term, industry allocation will be adjusted; in the long term, the focus will return to fundamental research, and turnover will decrease [49][50]. - Product innovation: The development of equity and fixed - income + products will be promoted to meet market demand [53][57]. - Research and investment capabilities: The co - management model may become the future development trend of the industry [58]. 2. Impact on Public Funds: Analysis from Research and Investment, Products, Channels, Talent, and Back - end Operations - Research and investment: Benchmark constraints may force active equity funds to become "quasi - passive". The co - management model may be adopted to improve research and investment capabilities [63][58]. - Products: The passive trend will continue, and equity index products and fixed - income + products will have development opportunities [69][74]. - Channels: Public funds should strengthen self - sales and investment advisory channels to reduce dependence on代销 channels. The combination of fund investment advisory and direct sales platforms may bring opportunities for large public funds to enter the wealth management market [78][84]. - Talent: For researchers, the "department wall" between research and investment should be broken; for fund managers, hierarchical management should be implemented [90][93]. - Back - end operations: Fee reduction will raise the break - even point, and financial technology may be an effective means to cope with fee reduction in the short term [94][95]. 3. Impact on Securities Companies: Analysis from Public Fund Business, Sales, and Allocation - Public fund business: The "Action Plan" will directly impact the income of publicly - held funds by securities companies, potentially compressing their profit contribution in the short term [102]. - Sales: The similar classification evaluation mechanism will benefit securities companies' sales, and they will maintain their advantage in selling equity index funds [106]. - Allocation: Securities companies should strengthen research on high - weight benchmark targets and explore non - public fund customers [4]. 4. Investment Analysis Opinion - The non - banking financial sector can enjoy both Beta and Alpha, and its investment value is promising. The Beta logic lies in the promotion of the transformation of household savings into investments and the entry of long - term funds into the market. The Alpha logic is that the non - banking financial sector is under - allocated and has low valuations [4].

Group 1 - The core viewpoint emphasizes the need for cultivating patient capital to bridge the funding gap and cycle mismatch in the integration of technological and industrial innovation [1][2] - The China Securities Regulatory Commission (CSRC) chairman highlighted the importance of long-term capital in supporting the sustainable growth of technology enterprises [1][4] - Private equity funds play a crucial role in nurturing patient capital, as they align with the growth patterns of technology innovation and cover the financing needs throughout the lifecycle of tech companies [1][2] Group 2 - Recent data shows that private equity and venture capital funds have invested in 90% of companies listed on the Sci-Tech Innovation Board and over half of those on the Growth Enterprise Market [2] - As of April 2025, there are nearly 20,000 private fund managers managing over 140,000 funds with a total scale of 20 trillion yuan [2] - The CSRC plans to focus on enhancing the fundraising, investment, management, and exit processes of private equity funds to attract more long-term capital [2][3] Group 3 - The development of technology innovation indices can provide a safety net and value anchor for patient capital by accurately selecting technology assets with long-term growth potential [3] - The introduction of public funds with technology attributes can transform fragmented and short-term market funds into long-term capital supporting technological innovation [3] - Since the launch of the "Eight Measures for the Sci-Tech Innovation Board," multiple technology innovation indices have been released, significantly contributing to attracting incremental capital into the market [3][4] Group 4 - The continuous nurturing of patient capital is essential for the growth of technology and industrial innovation, with expectations for improved policy environments and diversified funding sources [4] - The capital market is anticipated to accelerate the cultivation of patient and long-term capital to support the growth of technology enterprises and the rise of emerging industries [4]

申万宏源研究资深高级研究员 袁宇泽 优化投资者结构、推动各类投资者协调发展是资本市场投资端改革的重要内容。申万宏源研究提出A股投资者结构"五分 法"并对不同类别的投资者持股比例及变化进行年度跟踪分析。通过对投资者结构的分析，我们可以更直观的判断各类投资主 体的行为、对市场投资风格的影响以及未来资本市场投资端改革的重点。近年来，我国持续加大引入中长期资金，以中央汇金 公司为代表的主体在关键时期积极入市投资，在稳定市场预期，增强资本市场内生稳定机制上发挥了重要作用。2024年末以产 业资本、政府持股、专业投资机构、个人大股东和一般个人投资者为代表的五大类投资者A股持股市值占比分别为34.4%、 7.6%、19.2%、6.4%和32.3%，与年初相比，产业资本、政府持股占比有一定的提升，专业投资机构和个人大股东持股占比略 微下降，一般个人投资者持股占比下滑。具体来看，2024年投资者结构呈现以下特征和变化： 一、产业资本和政府持股发挥市场"压舱石"作用 产业资本和政府持股近年来逆周期特征突出。与境外发达市场不同，我国股票市场除个人和机构持股之外，还有大量的产 业资本和政府类主体持股。由于产业资本和政府持股主体的持股 ...

6月20日，嘉实基金旗下嘉实成长共赢混合型证券投资基金（A类024433，C类024434）发布合同生效公告，标志着公募基金行业费率改革进入新阶段。该基 金自5月27日启动募集至6月17日结束，最终实现总净认购金额9.27亿元。 与此同时，嘉实基金于6月17日对旗下22只指数产品实施场内简称优化，涉及中证A系列、稀土、医药、黄金等多只核心宽基和行业主题类ETF。此次更名采 用"标的指数+ETF+管理人名称"或"标的指数+ETF"的标准化命名规则，旨在提升投资者对产品的识别效率，推动ETF市场规范化发展。 | 基金募集申请获中国证监会 | | 证监许可〔2025〕1095 号 | | --- | --- | --- | | 核准的文号 | | | | 基金募集期间 | | 2025年5月27日至2025年6月17日 | | 验资机构名称 | | 容诚会计师事务所(特殊普通合伙) | | 募集资金划入基金托管专户 的目期 | | 2025年6月19日 | | 募集有效认购总户数(单位: | | 5564 | | 户) | | | | 份额类别 | 嘉实成长共赢混 | 嘉实成长共赢混 合计 | | | 合 A | ...

与量化私募的谨慎相比，部分知名主观私募在年初市场回暖时迎来募资小高峰。睿郡资产旗下由董承非管理的产品自6月8日起暂停新客户申购。据渠道透 露，董承非产品年初募集"小几十亿"。重阳投资、宁泉资产、仁桥资产等大型主观私募今年以来也获得银行渠道等带来的可观增量，重阳投资相关人士透 露，今年合计申购规模近30亿元。 尽管头部私募募资火热，但整体私募发行市场冷热不均。业内人士指出，今年宏观环境、市场状况相对友好，量化私募业绩普遍较好，吸金能力更强，部分 热门产品甚至"秒光"，新兴绩优量化私募规模持续攀升。 相比之下，主观私募的"吸金"能力不及量化私募，难以再现2021年的募资盛况。大多数私募机构仍面临募资困境，部分机构甚至坦言"已躺平"，更有甚者因 前期业绩不佳，在产品开放时遭遇较大净赎回压力。 【环球网财经综合报道】近期，私募发行市场出现耐人寻味的景象：一边是百亿级量化私募衍复投资、宽德投资计划封盘，知名主观私募睿郡资产旗下明星 产品也已暂停申购；另一边，大多数私募机构仍面临募资难题，市场呈现冷热不均的态势。 衍复投资近日公告称，计划于7月1日起关闭旗下中证500、中证1000等指数增强产品的新客户申购。该机构最新管 ...

● 本报记者 王宇露 百亿级量化私募衍复投资近日公告称，基于公司业务发展的战略规划以及对投资者利益的综合考量，计 划于7月1日起关闭所有中证500、中证1000、万得小市值概念指数增强产品的新客户申购。无独有偶， 渠道人士6月18日透露，知名量化私募宽德投资也将在6月30日全渠道进行封盘。此前，百亿级主观私募 睿郡资产也曾宣布旗下明星基金经理董承非所管产品封盘。 尽管封盘的消息时有传出，不过从整体上来看，私募发行市场仍然呈现冷热不均的态势，产品热销现象 仅发生在极少数头部绩优私募上，大多数私募机构仍面临募资难题。 封盘现象频现 中国证券报记者近日从销售渠道处获悉，衍复投资近日发布公告称，计划于7月1日起关闭所有中证 500、中证1000、万得小市值概念指数增强产品的新客户申购，已持有投资者追加投资不受影响。 量化私募吸金能力更强 资料显示，2019年7月高亢创立衍复投资，2020年1月衍复投资第一只产品建仓运作。同年6月，其管理 规模破10亿元，同年10月管理规模破100亿元，仅用了不到一年半的时间就步入"百亿俱乐部"。据悉， 衍复投资最新管理规模超700亿元。私募排排网数据显示，截至今年5月底，衍复投资旗下 ...